Page 43 - Read Online

Page 12 of 17 Marasco et al. Hepatoma Res 2020;6:32 I http://dx.doi.org/10.20517/2394-5079.2019.54

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Therapy S, Resection L. Hepatocellular carcinoma (liver cancer) therapy. Johns Hopkins; 2012. pp. 2-9.
2. Dufour JF, Greten TF, Raymond E, Roskams T, De T, et al. Clinical practice guidelines EASL - EORTC clinical practice guidelines:
management of hepatocellular carcinoma European organisation for research and treatment of cancer. J Hepatol 2012;56:908-43.
3. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, et al. Is portal hypertension a contraindication to hepatic resection? Ann
Surg 2009;250:922-8.
4. Anna Elisabetta Brunetti S, Francesco Fiore Gennaro Daniele Radiologia Interventistica -Istituto Nazionale Tumori E, Pascale F,
Sperimentazioni cliniche -Istituto Nazionale Tumori -Napoli, Giuseppe Cabibbo -Napoli, Casadei Gardini A, et al. Coordinatore Bruno
Daniele UOC Oncologia-Ospedale del Mare-Napoli. 2018. Available from: https://www.aiom.it/wp-content/uploads/2018/11/2018_LG_
AIOM_Epatocarcinoma.pdf
5. Zhang ZQ, Xiong L, Zhou JJ, Miao XY, Li QL, et al. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term
survival after liver resection for different BCLC stages of HCC 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis.
World J Surg Oncol 2018;16.
6. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, et al. The “50-50 Criteria” on postoperative day 5 an accurate predictor of liver
failure and death after hepatectomy. Ann Surg 2005;242:824-9.
7. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, et al. Posthepatectomy liver failure: a definition and grading by the
international study group of liver surgery (ISGLS). Surgery 2011;149:713-24.
8. Wang YY, Zhao XH, Ma L, Ye JZ, Wu FX, et al. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess
preoperative hepatic functional reserve in patients with hepatocellular carcinoma. J Surg Oncol 2018;118:440-5.
9. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am 2004;84:355-73.
10. Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev
Gastroenterol Hepatol 2009;6:573-82.
11. Cucchetti A, Cescon M, Colecchia A, Neri F, Cappelli A, et al. Adding liver stiffness measurement to the routine evaluation of
hepatocellular carcinoma resectability can optimize clinical outcome. Eur J Ultrasound 2017;38:515-22.
12. Peng W, Li JW, Zhang XY, Li C, Wen TF, et al. A novel model for predicting posthepatectomy liver failure in patients with hepatocellular
carcinoma. PLoS One 2019;14:e0219219.
13. Cucchetti A, Cescon M, Golfieri R, Piscaglia F, Renzulli M, et al. Hepatic venous pressure gradient in the preoperative assessment of
patients with resectable hepatocellular carcinoma. J Hepatol 2016;64:79-86.
14. Zhang ZQ, Xiong L, Zhou JJ, Miao XY, Li QL, et al. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term
survival after liver resection for different BCLC stages of HCC. World J Surg Oncol 2018;16:208.
15. Phan K, An VVG, Ha H, Phan S, Lam V, et al. Hepatic resection for malignant liver tumours in the elderly: a systematic review and meta-
analysis. ANZ J Surg 2015;85:815-22.
16. Tanaka S, Ueno M, Iida H, Kaibori M, Nomi T, et al. Preoperative assessment of frailty predicts age-related events after hepatic resection:
a prospective multicenter study. J Hepatobiliary Pancreat Sci 2018;25:377-87.
17. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, et al. Development of a simple noninvasive index to predict significant fibrosis in
patients with HIV/HCV coinfection. Hepatology 2006;43:1317-25.
18. Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME, et al. The accuracy of the FIB-4 index for the diagnosis of mild
fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2009;29:409-15.
19. Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, et al. Validation of FIB-4 and comparison with other simple noninvasive indices for
predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010;30:546-53.
20. Wang H, Liu A, Bo W, Feng X, Hu Y, et al. Fibrosis-4 model influences results of patients with hepatocellular carcinoma undergoing
hepatectomy. Biomed Res Int 2018;2018.
21. Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of
hepatocellular carcinoma patients after curative hepatic resection. Surgery 2015;157:699-707.
22. Dong J, Zhang XF, Zhu Y, Ma F, Liu C, et al. The value of the combination of fibrosis index based on the four factors and future liver
remnant volume ratios as a predictor on posthepatectomy outcomes. J Gastrointest Surg 2015;19:682-91.
23. Zhou P, Chen B, Miao XY, Zhou JJ, Xiong L, et al. Comparison of FIB-4 index and child-pugh score in predicting the outcome of hepatic
resection for hepatocellular carcinoma. J Gastrointest Surg 2019;10-3.
24. Zhang ZQ, Yang B, Zou H, Xiong L, Miao XY, et al. ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver
failure in hepatocellular carcinoma patients. Medicine (Baltimore) 2019;98:e15168.
25. Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, et al. Predicting cirrhosis in patients with hepatitis C based on standard
laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282-92.
26. Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus